Abeona Therapeutics Announces Third Quarter 2016 Financial Results and Recent Clinical Highlights

Go back to Abeona Therapeutics Announces Third Quarter 2016 Financial Results and Recent Clinical Highlights

Abeona Therapeutics (ABEO) Tops Q3 EPS by 11c

November 10, 2016 7:45 AM EST

Abeona Therapeutics (NASDAQ: ABEO) reported Q3 EPS of ($0.08), $0.11 better than the analyst estimate of ($0.19). Revenue for the quarter came in at $184 thousand versus the consensus estimate of $240 thousand.

Cash, cash equivalents and marketable securities as of September 30, 2016 were $31.2 million, compared to $34.3 million... More